UAE says Chinese coronavirus vaccine 86% effective, offers few details

The United Arab Emirates said Wednesday a Chinese coronavirus vaccine tested in the federation of sheikhdoms is 86 per cent effective, though it released few details.

The UAE, home to Dubai and Abu Dhabi, conducted a trial involving 31,000 volunteers from 125 nations. Volunteers between 18 and 60 years old received two doses of the vaccine over 28 days.

The UAE's Health and Prevention Ministry announced the results via a statement on the state-run WAM news agency, saying they have reviewed Sinopharm CNBG's interim analysis of the Phase III trials. The analysis shows no serious safety concerns, the statement said.

It wasn't immediately clear if the announced results included only those taking part in the testing in the UAE or if they also include results from China and elsewhere. The statement described the vaccine as receiving official registration without elaborating on what that meant. Emirati officials could not be immediately reached for comment.

The Sinopharm vaccine has been approved for emergency use in a few countries and the company is still conducting late-stage clinical trials in 10 countries. Morocco is gearing up for an ambitious Covid-19 vaccination program, aiming to vaccinate 80% of its adults in an operation starting this month that's relying initially on the Sinopharm vaccine.

Sinopharm's shot relies on a tested technology, using a killed virus to deliver the vaccine, similar to how polio immunizations are made. Leading Western competitors use newer, less-proven technology to target the coronavirus' spike protein using RNA.

Top officials in the UAE, including Dubai's ruler Sheikh Mohammed bin Rashid Al Maktoum, have publicly receive the shots as part of the vaccine testing.



Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.

We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

Business Standard is now on Telegram.
For insightful reports and views on business, markets, politics and other issues, subscribe to our official Telegram channel